These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30542729)

  • 41. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
    Szulawska A; Arkusinska J; Czyz M
    Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apoptotic Melanoma B16-F1 Cells Induced by Lidamycin Could Initiate the Antitumor Immune Response in BABL/c Mice.
    Yang JL; Qin Y; Li L; Cao CY; Wang Q; Li Q; Lv YF; Wang Y
    Oncol Res; 2016 Jan; 23(1-2):79-86. PubMed ID: 26802654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of lidamycin on mitochondria initiated apoptotic pathway in human cancer cells].
    Qiu Q; Wang Z; Jiang JM; Li DD
    Yao Xue Xue Bao; 2007 Feb; 42(2):132-8. PubMed ID: 17518039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.
    Shi D; Liu Y; Xi R; Zou W; Wu L; Zhang Z; Liu Z; Qu C; Xu B; Wang X
    Int J Nanomedicine; 2016; 11():5823-5835. PubMed ID: 27853367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
    Jakubowska J; Wasowska-Lukawska M; Czyz M
    Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.
    Liang YX; Zhang W; Li DD; Liu HT; Gao P; Sun YN; Shao RG
    World J Gastroenterol; 2004 Sep; 10(18):2632-6. PubMed ID: 15309709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of cell proliferation and induction of apoptosis in K562 human leukemia cells by the derivative (3-NpC) from dihydro-pyranochromenes family.
    Rahimi R; Mahdavi M; Pejman S; Zare P; Balalaei S
    Acta Biochim Pol; 2015; 62(1):83-8. PubMed ID: 25750940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
    Liu HZ; Li DD; Zhen YS; Shao RG
    Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
    Li J; Xue L; Hao H; Han Y; Yang J; Luo J
    Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyphyllin D induces apoptosis and differentiation in K562 human leukemia cells.
    Yang C; Cai H; Meng X
    Int Immunopharmacol; 2016 Jul; 36():17-22. PubMed ID: 27104314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy.
    Yan HW; Hu WX; Zhang JY; Wang Y; Xia K; Peng MY; Liu J
    Tumour Biol; 2014 Jun; 35(6):5381-8. PubMed ID: 24526417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
    Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Recombinant and Reconstituted Novel Albumin-Lidamycin Conjugate Shows Lasting Tumor Imaging and Intensively Enhanced Therapeutic Efficacy.
    Li L; Hu L; Zhao CY; Zhang SH; Wang R; Li Y; Shao RG; Zhen YS
    Bioconjug Chem; 2018 Sep; 29(9):3104-3112. PubMed ID: 30105903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells.
    Klimaszewska-Wiśniewska A; Grzanka D; Czajkowska P; Hałas-Wiśniewska M; Durślewicz J; Antosik P; Grzanka A; Gagat M
    Int J Oncol; 2019 Dec; 55(6):1261-1274. PubMed ID: 31638196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β-catenin pathway.
    Chen Y; Yu D; Zhang C; Shang B; He H; Chen J; Zhang H; Zhao W; Wang Z; Xu X; Zhen Y; Shao RG
    Mol Carcinog; 2015 Jan; 54(1):1-8. PubMed ID: 23857500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour.
    Kimoto T; Hino K; Koya-Miyata S; Yamamoto Y; Takeuchi M; Nishizaki Y; Micallef MJ; Ushio S; Iwaki K; Ikeda M; Kurimoto M
    Pathol Int; 2001 May; 51(5):315-25. PubMed ID: 11422788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
    Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characterization of cell death induced by anticancer antibiotic lidamycin in human hepatoma BEL-7402 cells].
    He QY; Liang YY; Wang DS; Li DD
    Yao Xue Xue Bao; 2001 Mar; 36(3):174-8. PubMed ID: 12580082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.